biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on Aug 17, 2017 12:35pm

105 Views

Post# 26592319

RE:RE:choices

KayakerBC, you are so correct about Jekyl, he is just a troll now. These things take longer than expected but I think his estrogen levels have now surpassed his testosterone levels. Now he just acts like a cantankerous old man. Such a shame really, he's used to offer some really good insight. Oh well, it's a great buying opportunity for him and for the rest of us :).

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute